Namandje Bumpus, Director of Recursion Pharmaceuticals RXRX, has filed 0 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $28.1K. The latest trade was on 06/18.

NB

NB

Namandje Bumpus

Director

Company

Recursion Pharmaceuticals RXRX

First filing

25/03/19

Trades

7 trades

Buys / sales

0 / 2

12-month net buying

−$28.1K

Last trade

06/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	06/18	06/22	3,963 sh	$3.18	$12,602.34	−3.0%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	06/03	06/04	4,386 sh	$3.54	$15,526.44	−9.2%